Tyche Industries informs about updates

08 Jan 2025 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Tyche Industries has informed that, the United States Food & Drug Administration (USFDA) completed inspection of its manufacturing facility situated at Kakinada, Andhra Pradesh during August, 2024 and issued Seven observations. Further informed that United States Food & Drug Administration (USFDA) has classified the inspection as ‘Official Action Indicated’ (OAI). The Company remains committed to work closely with the USFDA and continues to enhance its compliance on an ongoing basis. The company will work with the USFDA to resolve these issues at the earliest. 

The above information is a part of company’s filings submitted to BSE.

Tyche Inds Share Price

133.05 -3.85 (-2.81%)
28-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...